Psychopharmacology and Pregnancy | Treatment Efficacy, Risks, and Guidelines | ISBN 9783642545610

Psychopharmacology and Pregnancy

Treatment Efficacy, Risks, and Guidelines

herausgegeben von Megan Galbally, Martien Snellen und Andrew Lewis
Mitwirkende
Herausgegeben vonMegan Galbally
Herausgegeben vonMartien Snellen
Herausgegeben vonAndrew Lewis
Buchcover Psychopharmacology and Pregnancy  | EAN 9783642545610 | ISBN 3-642-54561-0 | ISBN 978-3-642-54561-0

“Psychopharmacology and Pregnancy: Treatment Efficacy, Risks, and Guidelines provides guidance on the psychopharmacologic treatment of both pregnant women and women considering pregnancy, and it addresses several important topics to keep in mind when treating this special population, including consent procedures, ongoing critical review of the literature, and available alternative treatments. It would be a valuable reference to any clinician who may potentially treat peripartum women.” (Annette M. Matthews, Journal of Clinical Psychiatry, Vol. 76 (6), June, 2015)

“This book surveys the occurrence of mental illness in pregnancy and explains recommendations for treating pregnant patients with these disorders. … Any clinician who cares for pregnant women would benefit from using this book, but it is particularly relevant for those working at the interface of mental health and obstetrics. … It serves as an excellent tool for all those who are caring for pregnant women with mental illness.” (Sheila Lahijani, Doody’s Book Reviews, November, 2014)

Psychopharmacology and Pregnancy

Treatment Efficacy, Risks, and Guidelines

herausgegeben von Megan Galbally, Martien Snellen und Andrew Lewis
Mitwirkende
Herausgegeben vonMegan Galbally
Herausgegeben vonMartien Snellen
Herausgegeben vonAndrew Lewis
This book examines the role of psychopharmacological treatment in a range of disorders that may be encountered during pregnancy, including major depressive disorders, anxiety disorders, bipolar affective disorder, schizophrenia, eating disorders and substance abuse. The natural history of each condition pre and post-partum is analyzed and the evidence for the efficacy of drug treatments, evaluated. Special attention is paid to the potential dangers of different treatment options for both mother and fetus, covering risks of malformation, pregnancy and obstetric risks, neonatal risks and possible long-term consequences. The risks of not treating a particular condition are also analyzed. On the basis of the available evidence, management guidelines are provided that additionally take into account non-pharmacological options. Closing chapters consider the value of complementary and alternative medicine and ECT and explore future research directions.